May 19, 2010 – The American College of Cardiology (ACC) and Roche Diagnostics began collaboration to develop a peer-reviewed biomarkers clinical resource Web portal.

May 19, 2010 – A high-performance balloon dilatation catheter designed for use in peripheral angioplasty procedures below the knee was released today in both the United States and Europe. Boston Scientific said the Sterling SL Percutaneous Transluminal Angioplasty (PTA) Balloon Dilatation Catheter was developed specifically to address physicians’ needs in treating below-the-knee arteries.

May 18, 2010 – A pulse oximeter that integrates with a telehealth platform is designed for ease of use by patients and clinicians. Cardiocom's new pulse oximeter can be added to its telehealth system, along with its other accessories for blood pressure and a weight scale.

May 17, 2010 – When patients present with chest pain or other high-risk symptoms of heart problems, doctors increasingly rely on nuclear imaging and computed tomography (CT) to find evidence of heart disease. Results of these procedures can help guide life-saving prevention and treatment options.

May 17, 2010 – The first clinical cases using an irrigated ablation catheter were recently completed in the European Union, following recent CE Mark approval. The Thermocool SF irrigated ablation catheter is designed for use by electrophysiologists in treating cardiac arrhythmias.

May 17, 2010 – The Society for Cardiovascular Angiography and Interventions (SCAI) recently announced the creation of the Accreditation for Cardiovascular Excellence (ACE) organization.

May 17, 2010 – New STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial data showing the number of paroxysmal atrial fibrillation (AF) patients reporting AF symptoms declined by 80 percent after treatment with the Arctic Front Cardiac CryoAblation Catheter System.

May 14, 2010 – New evidence demonstrates key shock-reduction programming strategies significantly reduced implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) shocks from 17 to 28 percent. The study also identified programming and patient characteristics that increased the risk of shocks.

May 14, 2010 — A partnership to develop cardiovascular genomic diagnostic testing devices has been signed between GE Healthcare and CardioDx.

May 14, 2010 – Research published in the April issue of The Journal of Simulation in Healthcare demonstrates the potential for high-fidelity simulations in assessing the performance of interventional cardiologists.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now